The food and drug agency of Indonesia has approved the single-dose COVID-19 vaccine of US pharmaceutical company Johnson and Johnson (NYSE:JNJ) for emergency use, Reuters news agency reported on Tuesday.
This vaccine is produced by Janssen Pharmaceutical Companies, a part of Johnson & Johnson.
The agency has also approved emergency use of Chinese vaccine company CanSino Biological Inc's (HKG:6185) COVID-19 vaccine.
GSK secures EU approval for fully liquid Menveo vaccine
Scancell reports promising SCOPE trial data for SCIB1 in advanced melanoma
Transgene teams up with ProBioGen for individualised cancer vaccines
Bio-Works Technologies AB secures LOI for vaccine manufacturing product
LakeShore Biopharma's Phase III YSJA Rabies Vaccine clinical trial receives Chinese NMPA approval
Merck's CAPVAXIVE shows promising immune responses in adults at risk of pneumococcal disease
GSK PLC announces acceptance of NDA for gepotidacin by US FDA